| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 02/07/2007 | CN1298323C Fused pyrrolocarbazoles against inflammation |
| 02/07/2007 | CN1298319C Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
| 02/06/2007 | US7173134 retinoid X receptors ("RXRs"); useful for the treatment of diabetes (NIDDIM) and obesity; for example, 3-{4-[(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)methyl]-2-furyl}-2-propenoic acid |
| 02/06/2007 | US7173047 Benzo (f) insoindol derivatives and their use as ep4 receptor ligands |
| 02/06/2007 | US7173042 Quinoline inhibitors of cGMP phosphodiesterase |
| 02/06/2007 | US7173040 4-phenyl-6-alpha-(imidazolyl-, 1,2,4-triazolyl- or pyridyl)-benzyl substituted |
| 02/06/2007 | US7173038 Treatment of diseases such as cancer or arthritis |
| 02/06/2007 | US7173037 Compounds for trearment of cardiovascular disorders and hypotensive agents |
| 02/06/2007 | US7173027 Provide a physiological effect to a subject |
| 02/06/2007 | US7172893 Virus vectors and methods of making and administering the same |
| 02/06/2007 | US7172769 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery |
| 02/06/2007 | CA2362816C Valdecoxib compositions |
| 02/01/2007 | WO2007013661A1 Percutaneously absorbable ophthalmic preparation |
| 02/01/2007 | WO2007013591A1 Non-invasive drug delivery system targeting posterior eye tissue using gel composition |
| 02/01/2007 | WO2007013590A1 Non-invasive drug delivery system targeting posterior eye tissue using solid composition |
| 02/01/2007 | WO2007013147A1 Angiogenesis inhibitor and vascular regressive agent |
| 02/01/2007 | WO2007012645A1 Novel lasek laser eye surgery |
| 02/01/2007 | WO2006015016A3 Photodynamic therapy and compositions for treating ocular glaucoma |
| 02/01/2007 | US20070028315 DNA encoding SNORF33 receptor |
| 02/01/2007 | US20070027200 Bis-benzimidazoles and related compounds as potassium channel modulators |
| 02/01/2007 | US20070027197 Pharmaceutical composition and method for the treatment of diseases using HMG-CoA reductase inhibitors and insulin secretion enhancers or sensitizers |
| 02/01/2007 | US20070027101 Treating ocular neovascular disease using anti-VEGF therapy in combination with a second therapy that inhibits the development of ocular neovascularization or destroys abnormal blood vessels in the eye, such as photodynamic therapy |
| 02/01/2007 | US20070026422 Vaccine-induced hepatitis B viral strain and uses thereof |
| 02/01/2007 | US20070025994 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 02/01/2007 | US20070025993 Tek antagonists |
| 02/01/2007 | US20070025913 Immunoglobulin which specifically binds endothelial cell-specific polypeptides; for use as evaluative tool in immunodiagnostic and drug efficacy studies |
| 02/01/2007 | CA2617040A1 Non-invasive drug delivery system targeting posterior eye tissue using solid composition |
| 01/31/2007 | EP1748048A1 Imidazopyridine compound |
| 01/31/2007 | CN1906159A Prostaglandin nitrooxyderivatives |
| 01/31/2007 | CN1903218A Medicine for treating otitis media |
| 01/31/2007 | CN1903188A Application of teprenone for preparing medicine for treating and/or preventing glaucoma |
| 01/31/2007 | CN1297554C Amido ether substituted imidazoquinolines |
| 01/31/2007 | CN1297548C Cyclic hemiacetal derivative and use thereof |
| 01/31/2007 | CN1297546C Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 01/31/2007 | CN1297275C The use of an anti-allergy agent and a steroid to treat allergic rhinitis |
| 01/31/2007 | CN1297270C Ophthalmic composition comprising ascomycin |
| 01/30/2007 | US7169929 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 01/30/2007 | US7169925 Indole derivatives as interleukin-4 gene expression inhibitors |
| 01/30/2007 | US7169817 Treatment and/or prevention of diseases or disorders mediated by lymphocyte interactions. |
| 01/30/2007 | US7169787 e.g., N-(4-pyridylmethyl)-1-cyclopropylmethyl-7-azaindole-3-carboxylic acid amide |
| 01/30/2007 | US7169778 Antiproliferative agents; anticancer agents; central nervous system disorders; antiarthritic agents |
| 01/30/2007 | US7169767 Ophthalmic compositions containing galactomannan polymers and borate |
| 01/30/2007 | US7169603 Nucleic acid; a nucleotide sequence encoding a fusion polypeptide; fusion polypeptides containing alpha -MSH can be used to elicit a variety of biological responses, in vitro and in vivo |
| 01/30/2007 | US7169565 Isolated antibody that specifically binds to a polypeptide encoded by polynucleotides composed of any polyribonucleotide or polydeoxribonucleotide, which may be unmodified RNA or DNA or modified RNA or DNA |
| 01/30/2007 | US7169389 Human CD154 binding molecules and treatment methods |
| 01/30/2007 | CA2468771C Pharmaceutical composition for use in ophthalmology and rhinology |
| 01/30/2007 | CA2350573C Piperidines as ccr5 modulators |
| 01/25/2007 | WO2007011873A2 Method for treating intraocular neovascular diseases |
| 01/25/2007 | WO2007011720A2 Cyclopentane n-lower alkyl heptenamide-5-cis-2- (3alapha- hydroxy-5-phenylpentyl) -3, ?5-dihydroxy, [1alpha, 2beta, 3alpha, 5alpha] compounds as agents for lowering intraocular pressure |
| 01/25/2007 | WO2007010965A1 Azaindole derivative having pgd2 receptor antagonistic activity |
| 01/25/2007 | WO2007010383A1 Novel heterocyclidene acetamide derivative |
| 01/25/2007 | WO2007009359A1 Thymosin beta 4 derivatives and use thereof |
| 01/25/2007 | WO2006085144A3 Compositions containing high omega-3 and low saturated fatty acid levels |
| 01/25/2007 | WO2006068899A3 Preserved ophthalmic compositions comprising aloe vera |
| 01/25/2007 | US20070021503 Ophthalmic fluid |
| 01/25/2007 | US20070021494 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 01/25/2007 | US20070021476 Neuroprotectants; treatment of neuropathies resulting from chemtherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases; neurodegenerative diseases; enzyme inhibitors for seine/threonine kinases, phosphatases; Alzheimer' |
| 01/25/2007 | US20070021464 Methods and compositions for inhibition of angiogenesis with EM-12 Derivatives |
| 01/25/2007 | US20070021416 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides |
| 01/25/2007 | US20070021386 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| 01/25/2007 | US20070021334 Class III slrp agonists for the reduction of blood vessel formation |
| 01/25/2007 | US20070017508 Methods for treating jaw pain |
| 01/25/2007 | CA2615990A1 Enhanced ocular neuroprotection/neurostimulation |
| 01/25/2007 | CA2615360A1 Formulation and method for administration of ophthalmologically active agents |
| 01/25/2007 | CA2615231A1 Prevention and treatment of ophthalmic complications of diabetes |
| 01/25/2007 | CA2578613A1 Binding domain fusion proteins |
| 01/24/2007 | EP1746095A1 Indanol derivative |
| 01/24/2007 | EP1744759A2 Use of loteprednol etabonate for the treatment of dry eye |
| 01/24/2007 | EP1744736A1 Method of treating dry eye disorders and uveitis |
| 01/24/2007 | EP1461070B1 Combined use of a glp-1 compound and an aldose reductase inhibitor |
| 01/24/2007 | EP1377555B1 A dioxino[2,3-g]quinoline-9-carboxylic acid derivative as nk3 receptor antagonist |
| 01/24/2007 | EP1339386B1 Reversible gelling system for ocular drug delivery |
| 01/24/2007 | EP1174151B1 Therapeutic treatment of eosinophilia using chymase inhibitors as the active ingredient |
| 01/24/2007 | CN1902176A Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment |
| 01/24/2007 | CN1901938A Combination of a DPP-IV inhibitor and an anti-obesity or appetite regulating agent |
| 01/24/2007 | CN1899609A Pneumococcus polysaccharide protein coupling vaccine and its preparing method |
| 01/24/2007 | CN1899448A Chinese medicine compound preparation for treating amblyopia and its preparing method |
| 01/24/2007 | CN1899339A Medicinal composition for treating acute and chronic conjunctivitis for eye and its preparing method |
| 01/24/2007 | CN1899304A Eye drops for cataract and its preparing method |
| 01/24/2007 | CN1899286A Racanisodamine eye drops |
| 01/24/2007 | CN1296381C VEGF peptides and their use for inhibiting angiogenesis |
| 01/24/2007 | CN1296365C Imidazolinylmethyl aralkylsulfonamides |
| 01/24/2007 | CN1296356C CCR-3 receptor antagonists VII |
| 01/24/2007 | CN1296346C Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 01/24/2007 | CN1296067C Drink for protecting eye |
| 01/24/2007 | CN1296052C Non-injection preparation containing medium and/or low molecular weight chondroitin sulfate |
| 01/24/2007 | CN1295974C Eyesight-improving tea of Chinese wolfberry fruit and chrysanthemum |
| 01/23/2007 | US7166726 Aryl substituted 3,4-dihydroanthracene derivatives having retinoid antagonist or retinoid inverse agonist type biological activity |
| 01/23/2007 | US7166722 The monohydrochloric acid salt monohydrate, and its preparation by adding hydrochloric acid to a solution of N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl)urea in an N,N-dimethylformamide or N,N-dimethylacetamide aprotic solvent, adding ethanol and ethanol and water |
| 01/23/2007 | US7166640 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract |
| 01/23/2007 | US7166625 Method for treating fibrotic diseases and other indications |
| 01/23/2007 | US7166623 Pain and inflammation |
| 01/23/2007 | US7166618 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 01/23/2007 | US7166605 Prophylaxis; endothelial diseases, oxidative stress, cardiovascular, inflammatory, cardiovascular, ocular, autoimmune diseases, neurological disorders and cancer, hypercholesterolemia and hyperlipidemia |
| 01/23/2007 | US7166598 Piperazine derivatives |
| 01/23/2007 | US7166593 Glucocorticoid receptor modulators |
| 01/23/2007 | US7166592 Antiinflammatory agents |
| 01/23/2007 | US7166586 Sulfonamide lactam inhibitors of FXa and method |
| 01/23/2007 | US7166583 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 01/23/2007 | US7166472 Adding a reducible redox-active metal to a first and a second target protein sample of an auto-oxidizing kynurenine pathway metabolite; incubating to allow cross-linking of target protein, comparing the amounnt of target protein cross-linking |